Frontiers in Oncology (Feb 2021)

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

  • Federico La Manna,
  • Federico La Manna,
  • Marta De Menna,
  • Nikhil Patel,
  • Sofia Karkampouna,
  • Maria Rosaria De Filippo,
  • Maria Rosaria De Filippo,
  • Irena Klima,
  • Peter Kloen,
  • Lijkele Beimers,
  • George N. Thalmann,
  • Rob C. M. Pelger,
  • Estela Jacinto,
  • Marianna Kruithof-de Julio,
  • Marianna Kruithof-de Julio

DOI
https://doi.org/10.3389/fonc.2021.650623
Journal volume & issue
Vol. 11

Abstract

Read online

No abstracts available.

Keywords